“ipo” Archives

in
Entry Author Date Location
The Xconversation: Software CEO Meets University Innovation Leader, Part II 06/08/16 Seattle
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Spine Medical Device Firm LDR Holdings Bought by Zimmer Biomet for $1B 06/07/16 Texas
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Seattle Week in Review: Give Me the Blue Pill 06/03/16 Seattle
Impinj to Test IPO Waters Again, Seeking to Raise Up to $60M 06/03/16 Seattle
Boston Tech Watch: Stumbling Startups, China VC, Acquisitions & More 06/03/16 Boston
Eyeing Further Growth, Social Marketer Spredfast Nabs Another $50M 06/01/16 Texas
RA Capital Seeds Peanut Allergy Prevention Startup With $1.7M 06/01/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Localytics Pushes Toward Profits After Layoffs and Market Slowdown 05/23/16 Boston
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate 05/18/16 Texas
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound 05/16/16 San Francisco
CarGurus CEO on Profitable Tech Startups, and Why Uber Is Road Kill 05/16/16 Boston
Wall Street Bids Up Acacia in 2nd Tech IPO of 2016, 1st in MA 05/13/16 Boston
CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares 05/05/16 Boston
Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal 05/05/16 Boston
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More 04/14/16 Boston
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push 04/13/16 Boston
CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue 04/11/16 Boston
Five Takeaways from “What’s Hot in Boston Biotech” 04/11/16 Boston
What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen 03/31/16 New York
Invitae Scales Up DNA Test Offerings, Scores Mild Market Bump 03/29/16 San Francisco
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Post NexGen Purchase, Austin Software Firm Pivot3 Raises $55M 03/15/16 Texas
Page 3 of 22 « previous page · next page »